Cargando…
High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma
BACKGROUND: Current clinical risk factors stratify patients with neuroblastoma (NB) for appropriate treatments, yet patients with similar clinical behaviors evoke variable responses. MYCN amplification is one of the established drivers of NB and, when combined with high-risk displays, worsens outcom...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649748/ https://www.ncbi.nlm.nih.gov/pubmed/31360848 http://dx.doi.org/10.1093/jncics/pky015 |